Aperture Therapeutics Alternatives & Competitors

12 companies similar to Aperture Therapeutics — Diversity. Focus. Discovery.

NeuCyte

Decoding CNS Drug Discovery with SynFire® iP

11 Series A $6.70M

Mountain View, United Sta...

Biotechnology Health Care +2

Rubedo Life Sciences

Medicines to keep you biologically young by targeting the pathological cells that drive ch...

32 Series A $53.45M

Sunnyvale, United States

Biotechnology Health Care +1

Cognition Therapeutics, Inc.

Advancing Accessible Solutions for Complex Neurodegenerative Diseases

29 IPO $161.89M

United States

Biotechnology Health Care +3

Lodo Therapeutics Corporation

Clusters to cures: tapping evolution’s diversity to reinvent drug discovery

8 Acquired $17.00M

New York, United States

Biotechnology Health Care +1

Rival Readout

Competing with Aperture Therapeutics? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Gain Therapeutics

Unfolding the next generation of allosteric small molecule therapies to meet patient needs...

26 IPO $83.04M

Bethesda, United States

Biotechnology Pharmaceutical

Design Pharmaceuticals Inc.

Boundless GPCR drug discovery

3 Seed $5.00M

Cambridge, United States

Biotechnology Health Care +1

Appia Bio

Collaborates across a diversity of disciplines, which is critical to developing next-gener...

13 Series A $52.00M

Biotechnology Health Care +2

OliX Pharmaceuticals, Inc.

Contributing to the Health and Happiness of Mankind with RNAi Technology

38 Post-IPO Equity $41.50B

Korea South

Biotechnology Pharmaceutical

Catalyst Biosciences

12 Post-IPO Equity $301.31M

South San Francisco, Unit...

Biopharma Biotechnology +2

Praxis Precision Medicines, Inc.

The era of genetic neuroscience has arrived

244 IPO $1.66B

Boston, United States

Biotechnology Health Care +1

Tract Bio

Discovering and developing novel therapies to transform the treatment of cancer and inflam...

Boston, United States

Health and Wellness Life Sciences +1

Gero

AI-driven drug discovery company focused on therapies targeting age-related diseases

147 Series B $25.20M

Palo Alto, United States

AI Biotechnology +2

Frequently Asked Questions

Companies similar to Aperture Therapeutics include NeuCyte, Rubedo Life Sciences, Cognition Therapeutics, Inc., Lodo Therapeutics Corporation, Gain Therapeutics. They work in Biotechnology and Pharmaceutical.

Bounce Watch lists 12 companies that share Aperture Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Aperture Therapeutics is a pre-clinical stage drug discovery company with a focus on age-related neurodegenerative disorders. Established in 2022 and headquartered in the United States, the company's slogan "Diversity. Focus.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Aperture Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Aperture Therapeutics Profile NeuCyte Alternatives Rubedo Life Sciences Alternatives Cognition Therapeutics, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.